Skip to main content
. Author manuscript; available in PMC: 2022 May 26.
Published in final edited form as: Diabetes Obes Metab. 2022 Jan 25;24(5):881–890. doi: 10.1111/dom.14646

FIGURE 3.

FIGURE 3

Change from baseline in liver fibrosis and insulin sensitivity up to week 12. A, Overall mean (standard deviation [SD]) changes in liver fibrosis. B, Mean (SD) percentage changes in liver fibrosis in patients with nonalcoholic steatohepatitis (NASH) and those with NASH and type 2 diabetes. C, Overall mean (SD) changes in insulin sensitivity. D, Overall mean (SD) changes in hepatic insulin sensitivity (Siliver). P values presented are Wilcoxon rank-sum tests